NCT05547399View on ClinicalTrials.gov

Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

December 7, 2022

Study Completion Date

December 7, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Zanubrutinib

Administered orally as a tablet or capsule

Trial Locations (1)

75247

Fortrea Clinical Research Unit, Dallas

Sponsors

Lead Sponsor

BeiGene
All Listed Sponsors
lead

BeiGene

INDUSTRY

NCT05547399 - Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults | Biotech Hunter | Biotech Hunter